Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
AbbVie and Scripps Research announced a global collaboration to develop potential novel, direct-acting antiviral treatments for COVID-19.
read more
Elektrofi & IPA announced they are entering into a collaboration to explore a high-concentration formulation of IPA’s COVID-19 antibody cocktail, PolyTope® TATX-03. This collaboration aims to generate...
read more
Wednesday, March 09, 2022
Johnson & Johnson announced the completion of a landmark agreement between Janssen Pharmaceuticals, Inc., and manufacturer Aspen SA Operations (Pty) Ltd, based in South Africa, to enable the first ...
read more
Wednesday, March 02, 2022
SAB Biotherapeutics reported that due to low hospitalization and death rates in the trial, the National Institutes of Health’s (NIH) ACTIV-2 Program is discontinuing enrollment in its Phase 3 COVID-19...
read more
Monday, February 28, 2022
Vaccines have revolutionized the world’s ability to prevent, mitigate the impact of and, in some cases, eliminate the threat of certain infectious diseases and improve overall health. The clinical ...
read more
Monday, February 28, 2022
All hand sanitizers, whether used by consumers or healthcare professionals, are considered over-the-counter (OTC) drugs that are regulated by the FDA. The most common type of hand sanitizer has ...
read more
Monday, February 28, 2022
Seqirus announced the renewal of a five-year agreement with the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and...
read more
Friday, February 25, 2022
The FDA has revised the emergency use authorization for Evusheld (tixagevimab co-packaged with cilgavimab) to change the initial dose for the authorized use as pre-exposure prophylaxis (prevention) of...
read more
Friday, February 25, 2022
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) announced that Health Canada has granted approval for COVIFENZ®, COVID-19 vaccine, (plant-based virus-like...
read more
Thursday, February 24, 2022
Novavax, Inc. announced the first doses of Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) have begun shipping to European Union (EU) member states. Nuvaxovid, also known as NVX-CoV2373, is the ...
read more
Thursday, February 24, 2022
Moderna, Inc. and Thermo Fisher Scientific Inc. announced a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing in the U.S. of Spikevax®, Moderna’s COVID-19 vaccine...
read more
Friday, February 18, 2022
Health Canada authorized Novavax's Nuvaxovid COVID-19 vaccine for the prevention of COVID-19 in adults 18 years of age and older. This is the fifth COVID-19 vaccine authorized in Canada. After a ...
read more
Thursday, February 17, 2022
Alvea will begin to develop, test, and deliver DNA vaccines at scale to low and middle-income countries with limited access to existing vaccine options.
read more
Wednesday, February 16, 2022
BioNTech SE has taken a next step to improve vaccine supply in Africa. The company has introduced its approach to establishing scalable vaccine production by developing and delivering turnkey mRNA ...
read more
Tuesday, February 15, 2022
Novavax, Inc. announced its submission to Swissmedic, the Swiss Agency for Therapeutic Products, for conditional marketing authorization (CMA) of NVX-CoV2373, its recombinant nanoparticle protein-...
read more